ANALISIS KINERJA PROFITABILITAS SEKTOR FARMASI YANG TERDAFTAR DI BURSA EFEK INDONESIA SEBELUM DAN SAAT COVID-19

Dwi Aprilariadi ; Slamet Riyadi
JURNAL RISET EKONOMI DAN AKUNTANSI (JREA) 📅 2023 Vol 1, No 3 🔗 DOI: 10.54066/jrea-itb.v1i3.599
Abstract
This research is a type of quantitative research with the aim of to test the impact of Covid-19 on the company's financial performance pharmacy listed on the Indonesia Stock Exchange. This sample was taken from pharmaceutical companies listed on the Indonesia Stock Exchange (IDX) that can accessed through the website (www.idx.co.id). The population in this study were all pharmaceutical companies listed on the Indonesia Stock Exchange as many as 12 companies. The sample used in this study were 11 companies in the 2018-2021 period.The research method uses quantitative methods, the data used in this study is secondary data in the form of financial statements of pharmaceutical companies listed on the Indonesian stock exchange. Analysis of the data using a paired sample mean difference test Paired Sample Test using the SPSS application, and financial performance measurement using profitability ratios. Profitability ratios consist of Net Profit Margin, Rate of Return on Assets, and Return on Equity. The results showed that there was no significant difference to the financial performance of the profitability ratios of pharmaceutical companies listed on the IDX both before the Covid-19 pandemic and during the Covid-19 pandemic.
Keywords
Profitability Performance; Financial Ratios; Profitability; Covid-19
How to Cite

Dwi Aprilariadi & Slamet Riyadi (2023). ANALISIS KINERJA PROFITABILITAS SEKTOR FARMASI YANG TERDAFTAR DI BURSA EFEK INDONESIA SEBELUM DAN SAAT COVID-19. JURNAL RISET EKONOMI DAN AKUNTANSI (JREA), 1(3). https://doi.org/10.54066/jrea-itb.v1i3.599

Dwi Aprilariadi; Slamet Riyadi, "ANALISIS KINERJA PROFITABILITAS SEKTOR FARMASI YANG TERDAFTAR DI BURSA EFEK INDONESIA SEBELUM DAN SAAT COVID-19," JURNAL RISET EKONOMI DAN AKUNTANSI (JREA), vol. 1, no. 3, 2023.

Dwi Aprilariadi; Slamet Riyadi. "ANALISIS KINERJA PROFITABILITAS SEKTOR FARMASI YANG TERDAFTAR DI BURSA EFEK INDONESIA SEBELUM DAN SAAT COVID-19." JURNAL RISET EKONOMI DAN AKUNTANSI (JREA), vol. 1, no. 3, 2023.

Dwi Aprilariadi; Slamet Riyadi. "ANALISIS KINERJA PROFITABILITAS SEKTOR FARMASI YANG TERDAFTAR DI BURSA EFEK INDONESIA SEBELUM DAN SAAT COVID-19." JURNAL RISET EKONOMI DAN AKUNTANSI (JREA) 1, no. 3 (2023).

Dwi Aprilariadi & Slamet Riyadi (2023) 'ANALISIS KINERJA PROFITABILITAS SEKTOR FARMASI YANG TERDAFTAR DI BURSA EFEK INDONESIA SEBELUM DAN SAAT COVID-19', JURNAL RISET EKONOMI DAN AKUNTANSI (JREA), 1(3). doi: 10.54066/jrea-itb.v1i3.599.

Dwi Aprilariadi; Slamet Riyadi. ANALISIS KINERJA PROFITABILITAS SEKTOR FARMASI YANG TERDAFTAR DI BURSA EFEK INDONESIA SEBELUM DAN SAAT COVID-19. JURNAL RISET EKONOMI DAN AKUNTANSI (JREA). 2023;1(3).

Artikel Terkait

Analisis Literasi Keuangan dan Perilaku Keuangan terhadap Pengelolaan Keuangan Pribadi dan Uji Beda Antar Semester pada Mahasiswa Akuntansi FEB UNTAN

Lutfi Amin; Rudy Kurniawan; Ira Grania Mustika

The Impact of Online Reviews on Consumer Purchasing Decisions in E Commerce

Anthonius S. Hutabarat

Pengaruh Alokasi Dana Desa dan Pendapatan Asli Desa terhadap Belanja Desa di Desa-Desa Kecamatan Bone Raya

Wahyu Tomaili; Lukfiah Irwan Radjak; Mentari Ariesta Iyonu

Peran Strategis Tim Penggerak PKK dalam Meningkatkan Kemandirian Ekonomi Keluarga di Era Digital

Widiyanti Widiyanti; Ratna Tunjungsari; Agung Budiartono; Agus Prasetyo

Strategi Pengembangan Technopreneurship Mahasiswa di Era Digital: Kajian Literatur tentang Pendidikan Kewirausahaan, Literasi Digital, dan Inkubasi Bisnis

Putri Intan Sustoro; Bunga Nur Aulina; Flora Anjelika Safitri; Makmur Sujarwo

Peran Evaluasi Kinerja Manajemen pada Pengelolaan Program Doktor Ilmu Hukum Berbasis Kepemimpinan Transformasional dan Sistem Reward guna Meningkatkan Kualitas Lulusan

Yovita Arie Mangesti; Sayekti Suindyah Dwiningwarni
Tren Sitasi Jurnal